Abstract
Hepatitis B is one of the most important causes of chronic viral hepatitis world wide. Mutations in the precore region of the hepatitis B virus (HBV) genome are frequently found in hepatitis B envelope antigen-negative cases. Data from India on the HBV genotype-associated distribution of precore mutations are limited. Our objective in this study was to genotype and detect the precore mutant with a point mutation from G to A at nucleotide 1896 using ligase chain reaction (LCR) and direct sequencing. A total of 115 cases of chronic liver disease were screened. The cases were evaluated on the basis of history, clinical examination, liver function profile, and serological test for HBV infection, which includes HBsAg, anti HBcIgG, HBeAg using commercially available ELISA kits. The cases, which were HBeAg+, HBeAg–, and HBV DNA+, were subjected to LCR and confirmed by direct sequencing. Of 115 chronic liver disease cases, 50 (43.5%) cases were HBV DNA positive. All cases were subjected to LCR; 11 (22%) cases confirmed the presence of precore mutants, while the remaining 39 (78%) were classified as the wild form of the virus. HBV genotyping by direct sequencing revealed that genotype D was predominant in both wild and mutant forms of the virus. We conclude that the HBV genotype distribution was not significantly different between precore mutants and the wild form of the virus (P>0.05). North Indian patients with genotype D were more likely to have persistent HBV infection with precore mutants. HBV genotypes correlate with the clinical outcome of chronic HBV infection.
Similar content being viewed by others
References
Purcel RH (1993) The discovery of the hepatitis viruses. Gastroenterology 104:955–963
Kumar A, Kumar SI, Pandey R, Naik S, Aggarwal R (2005) Hepatitis B virus genotype A is more often associated with severe liver disease in northern India than is genotype D. Indian J Gastroenterol 24:19–22
Chu CJ, Lok AS (2002) Clinical significance of hepatitis B virus genotypes. Hepatology 35:1274–1276
Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) GenotypeH: a new Amerindian genotype of hepatitis B virus reveled in Central America. J Gen Virol 83:2059–2073
Blackberg J, Kidd-Ljunggren K (2003) Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma. J Med Virol 71(1):18–23
Yuen MF, Sablon E, Wong DK, Yuan HJ, Wong BC, Chan AO, Lai CL (2003) Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation. Clin Infect Dis 37(4):593–597
Chu CJ, Keeffe EB, Han SH, et al. (2003) Hepatitis B virus genotypes in the United States of a nation wide study. Gastroenterology 125:444–451
Carman WF, Ferrao M, LOK ASF, Ma OCK, Lai CL, Thomas HC (1992) Precore sequence variation in Chinese isolates of Hepatitis B virus. J Infect Dis 165:127–133
Brunetto MR, Stemler M, Schodel F, et al. (1989) Identification of HBV variant which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol Hepatol 21:151–154
Carman WF, Jacyna MR, Hadziyannis S, et al. (1989) Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2:588–591
Baumert TF, Marrone A, Vergalla J, Liang TJ (1998) Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J Virol 72(8):6785–6795
Kramvis A, Kew MC (1998) Structure and function of the encapsidation signal of hepadnaviridae. J Viral Hepat 5(6):357–367
Kosaka Y, Takase K, Kojima M, et al. (1991) Fuminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and core capable of encoding e antigen. Gastroenterology 100:1087–1094
Barany F (1991) Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc Natl Acad Sci USA 88(1):189–193
McMahon BJ, Bulkow L, Harpster A, et al. (2000) Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 32:842–846
Yuen MF, Cheng CC, Lauder IJ, et al. (2000) Early detection of hepatocellular carcinoma increases the chance of treatment—Hong Kong experience. Hepatology 31:330–335
Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337(24):1733–1745
Kao JH, Wu NH, Chen PJ, et al. (2000) Hepatitis B genotypes and the response to interferon therapy. J Hepatol 33:998–1002
Wai CT, Chu CJ, Hussain M, et al. (2002) HBV genotype B is associated with better response to interferon therapy in HBeAg-positive chronic hepatitis than genotype C. Hepatology 36:1425–1430
Erhardt A, Reineke U, Blondin D, et al. (2000) Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 31:716–725
Orito E, Mizokimi M, Sakugawa H, et al. (2001) A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotypes Research Groups. Hepatology 33:218–223
Ding X, Mizokami M, Yao G, Xu B, Ueda R (2001) Hepatitis virus genotype distribution among chronic hepatitis B virus carriers in Shanghai. China. Int Virol 44:43–47
Thakur V, Rehman S, Guptan RC, Kazim SN, Kumar S, Sarin SK (2002) Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian Subcontinent. J Gastroenterol Hepatol 17(2):113–115
Gandhe SS, Chadha MS, Arankalle VA (2003) Hepatitis B virus genotype and serotypes in western India: lack of clinical significance. J Med Virol 69(3):324–330
Grandjacques C, Pradat P, Stuyver L, et al. (2000) Rapid detection of genotypes and mutations in the precore promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity. J Hepatol 33:430–439
Lok ASF, Akarca U, Greene S (1994) Mutation in the pre-core region of hepatitis B virus severe to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc. Natl Acad Sci USA 91:4077–4081
Mangia A, Chung YH, Hoofnagle JH, Birkenmeyer L, Mushahwar I, Di Bisceglie Am (1996) Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg. Dig Dis Sci 41:2447–2452
Zuckerman AJ, Zuckerman JN (1999) Molecular epidemiology of hepatitis B virus mutants. J Med Virol 58:193–195
Hadziyannis SJ, Vassilopoulos D (2001) Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34:617–624
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kar, P., Polipalli, S.K., Chattopadhyay, S. et al. Prevalence of Hepatitis B Virus Genotype D in Precore Mutants Among Chronic Liver Disease Patients from New Delhi, India. Dig Dis Sci 52, 565–569 (2007). https://doi.org/10.1007/s10620-006-9625-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9625-z